CDC Health Advisory: Use of Ciprofloxacin or Doxycycline for Postexposure Prophylaxis for Prevention of Inhalational Anthrax
Interim recommendations for postexposure prophylaxis to prevent inhalational anthrax after exposure to B. anthracis spores recommend ciprofloxacin or doxycycline as initial therapy in situations assoc... Details >
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services |
CDC Responds: Treatment Options for Postal and Other Workers Exposed to Anthrax (December 21, 2001)
This broadcast provides new information for treatment options for prevention of inhalation anthrax for persons who were exposed to spores and are completing 60-day courses of prophylactic antibiotics.... Details >
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services |
CDC Responds: Update on Options for Preventive Treatment for Persons at Risk for Inhalational Anthrax (December 21, 2001)
This broadcast provides new information for treatment options for prevention of inhalation anthrax for persons who were exposed to spores and are completing 60-day courses of prophylactic antibiotics.... Details >
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services |
Children and Anthrax: A Fact Sheet for Clinicians
This CDC fact sheet dealing with bioterrorism describes inhalational, cutaneous, and gastrointestinal anthrax. It provides recommendations for pediatric post-exposure prevention and treatment.... Details >
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services |
Children and Anthrax: A Fact Sheet for Parents
This CDC fact sheet related to bioterrorism describes inhalational, cutaneous, and gastrointestinal anthrax and provides tips on what parents should know and how to reduce fears.... Details >
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services |
Clinical and Epidemiologic Principles of Anthrax
This article from Emerging Infectious Diseases describes the background and epidemiology of anthrax and discusses disease management.... Details >
National Center for Infectious Diseases, Centers for Disease Control and Prevention |
Department of Defense Anthrax Vaccine Immunization Program
This Department of Defense site provides information on the threat of anthrax as a weapon, the disease caused by anthrax, and the vaccine for anthrax. ... Details >
Department of Defense (DefenseLINK) |
Doxycycline and Penicillin G Procaine for Inhalational Anthrax (Post-Exposure)
This drug information sheet from FDA's Center for Drug Evaluation and Research provides recommendations for the antibiotics doxycycline and penicillin G procaine for treatment of inhalational anthrax.... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration |
Emergency Preparedness and Response: Training
Archived videos featuring experts from the Centers for Disease Control and Prevention and the National Institutes of Health providing information about anthrax and bioterrorism.... Details >
Centers for Disease Control and Prevention, U.S. Department of Health and Human Services |
Epidemiologic Information on Bioterrorism
This site provides educational information on possible biological weapons, considered in an epidemiologic and public health context. ... Details >
UCLA Department of Epidemiology |
